Bob Lobo Selected Research

Thrombocytopenia (Thrombopenia)

1/2008

Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bob Lobo Research Topics

Disease

1	COVID-19 11/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2010
1	Gangrene 01/2008
1	Thrombocytopenia (Thrombopenia) 01/2008
1	Hemorrhage 01/2008
1	Hyperalgesia 01/2004
1	Migraine Disorders (Migraine) 01/2004
1	Pain (Aches) 01/2004

Drug/Important Bio-Agent (IBA)

2	Warfarin (Coumadin)FDA LinkGeneric 12/2010 - 01/2008
1	Prothrombin (Factor II)IBA 12/2010
1	Factor VIIa (Activated Factor VII)IBA 12/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2008
1	Fondaparinux (Arixtra)FDA Link 01/2008
1	Tryptamines (Triptans)IBA 01/2004
1	Serotonin (5 Hydroxytryptamine)IBA 01/2004

Therapy/Procedure

2	Therapeutics 12/2010 - 01/2004
1	Personal Protective Equipment 11/2020
1	Contact Lenses 01/2004